National Canine Cancer Foundation Inc (EIN 030581083) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2006

Legal Domicile

Phone

9034249587

Tax Period

2024-01-01 to 2024-12-31

National Canine Cancer Foundation Inc, founded in 2006, is a small nonprofit in the Medical Research sector that reported $290K in total revenue in fiscal year 2024. Revenue fell 31% from the prior year — a significant decline worth monitoring. The organization ran a surplus of $65K, a strong 23% operating margin.

Mission

The National Canine Cancer Foundation strives to eliminate cancer as a major health problem in dogs through education outreach and research. They also help save lives through prevention finding cures better treatments more accurate cost effective diagnostic methods in dealing with cancer and diminishing dogs suffering from cancer.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $281,800

Program Service Revenue $7,939

Investment Income $0

Other Revenue $0

TOTAL REVENUE $289,739

Expense Breakdown

Grants Paid $2,600

Salaries & Benefits $144,695

Fundraising Expenses $54,062

Program Expenses $134,582

Other Expenses $77,084

TOTAL EXPENSES $224,379

Year-over-Year Comparison

	2024	2023	Change
Revenue	$289,739	$422,716	-0.3%
Expenses	$224,379	$440,470	-0.5%
Net Income	$65,360	$-17,754	-4.7%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$8,688

Total Directors

$40,728

Key Employees

$49,416

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Gary D Nice	President Director	10.00	Officer Key Emp	$8,688	$0	$8,688
Sara Nice	Director	40.00	Director Key Emp	$40,728	$0	$40,728
Bruce Shultz	Director	1.00	Director	$0	$0	$0
Elicia Calhoun	Director	1.00	Director	$0	$0	$0
Keith Cameron	Director	1.00	Director	$0	$0	$0
Dottie Simmons Parham	Director	1.00	Director	$0	$0	$0
Lyn Lenzio	Director	1.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$289,739	$224,379	$286,429	$65,360
2023	$422,716	$440,470	$236,629	$-17,754
2022	$356,605	$504,799	$267,121	$-148,194
2021	$474,707	$481,533	$292,937	$-6,826
2020	$366,056	$550,577	$257,030	$-184,521
2019	$537,764	$573,103	$224,520	$-35,339

National Canine Cancer Foundation Inc